(a) Representative responses to
LPA, cLPA, and the other mediators used for primer design in control
(upper trace) and PSP24 cRNA-injected (0.5 ng, lower trace) oocytes
from the same frog. Notice that the cLPA response is practically
identical in both cells, whereas the response to LPA is 2.5- to 3-fold
higher (10 nM and 1 nM, respectively). None of the other mediators
triggered an oscillatory response in either cell. (b)
LPA dose–response relationship in sham-injected control (open circles,
n = 4) and PSP24 cRNA-injected (solid squares,
n = 5) oocytes. The responses in PSP24
cRNA-expressing oocytes exceeded those of the controls and showed an
even more pronounced enhancement between 0.1 and 100 nM, contributing
to the high-affinity receptor for LPA. (c) An antisense
oligonucleotide designed from the sequence of amino acids 5–11 of
clone PSP24 inhibits both the endogenous and the induced
LPA response (n = 6 for all conditions). Injection
of PSP24 cRNA at 0.5 ng per oocyte (solid bar) approximately doubled
the response to 10 nM LPA in this experiment. Injection of ≈0.3 fmol
(2.5 pg) of the 18-mer antisense oligonucleotide (hatched bar) reduced
the endogenous response by 80%. To avoid the injection of
double-stranded RNA that triggers the activation of nucleases, oocytes
were injected a second time 2 days after the first injection with
either PSP24 cRNA or the antisense oligonucleotide. A second injection
of PSP24 cRNA (0.5 ng) into the oocytes (shaded bar) that were first
injected with antisense oligonucleotide caused an ≈1.5-fold increase
in the mean response over that of the distilled water-injected
(“sham-injected”) controls. A second injection of the antisense
oligonucleotide into oocytes that were first injected with PSP24 cRNA
inhibited the response 73% below the endogenous response.
All bars represent the mean response (±SEM) for six oocytes.
(d) The increase in the LPA response is selective and
dependent on the amount of PSP24 cRNA present. In this experiment,
oocytes were injected with a 1- to 200-fold dilution of a stock
solution of PSP24 cRNA (1 μg/μl, 50 nl per oocyte). A
constant amount (0.3 fmol) of antisense cRNA was mixed with and
coinjected with increasing dilutions of sense cRNA. Responses to 10 nM
LPA and 1 μM cLPA were measured 4–6 days after injection. Traces are
representative of four independent determinations
(n = 4). Note that the increase in the LPA response
decreased with the decreasing amount of PSP24 cRNA injected, whereas
the cLPA response was virtually unaffected in all groups. Injection of
0.3 fmol of antisense cRNA, alone, caused a 45% reduction in the
endogenous LPA response, whereas the cLPA response was
virtually unaltered.